Xinyu Lv
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dexamethasone activates anti-tumor immunity in multiple myeloma by dismantling the GR-PPP1CB complex to restore STING/IRF3 signaling.
Journal: Journal for immunotherapy of cancer
Published: June 08, 2026
NAT10-Mediated ac4C Modification of circANKRD12 Reprograms the Tumor Microenvironment.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 30, 2026
DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: October 22, 2025
GART promotes multiple myeloma malignancy via tumor stemness mediated by activating the HSP90α/CDK6/β-catenin axis.
Journal: European journal of pharmacology
Published: November 22, 2024
Extracellular vesicle-mediated delivery of circp53 suppresses the progression of multiple cancers by activating the CypD/TRAP/HSP90 pathway.
Journal: Experimental & molecular medicine
Published: November 10, 2024
SAE1 promotes tumor cell malignancy via SUMOylation and liquid-liquid phase separation facilitated nuclear export of p27.
Journal: Acta pharmaceutica Sinica. B
Published: August 21, 2024
Damage Tolerance of Superhydrophobic Coatings with Binary Cooperative Cells for Water Harvesting.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 30, 2023
ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells.
Journal: Oncology letters
Published: December 15, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026